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The surface glycoprotein hemagglutinin (HA) helps the influenza A virus to evade
the host immune system by antigenic variation and is a major driving force for
viral evolution. In this study, the selection pressure on HA of H5N1 influenza A
virus was analyzed using bioinformatics algorithms. Most of the identif ied positive
selection (PS) sites were found to be within or adjacent to epitope sites. Some of
the identif ied PS sites are consistent with previous experimental studies, providing
further support to the biological signif icance of our findings. The highest frequency
of PS sites was observed in recent strains isolated during 2005–2007. Phylogenetic
analysis was also conducted on HA sequences from various hosts. Viral drift is
almost similar in both avian and human species with a progressive trend over the
years. Our study reports new mutations in functional regions of HA that might
provide markers for vaccine design or can be used to predict isolates of pandemic
potential.
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Introduction
Influenza A viruses are immuno-epidemiologically sig-
nificant from an evolutionary standpoint (1 ). They
belong to the Orthomyxoviridae family and have
negative-sense single-stranded RNA with a genome
composed of eight different gene segments (2 ). Anti-
genic diversity of influenza A viruses occurs primar-
ily at two surface glycoproteins, hemagglutinin (HA)
and neuraminidase (NA). HA is a homotrimer; each
monomer is synthesized as a single polypeptide (HA0)
that is cleaved by host proteases into two subunits
(HA1 and HA2). HA1 mediates the initial contact
with the cell membrane and HA2 is responsible for
membrane fusion. The HA gene, as a target of neu-
tralizing antibodies, is a classic example of an anti-
genically drifting protein (3 ). This gene accumulates
an exceptional number of point mutations in the epi-
tope regions or antibody combining regions (4 ). Anti-
genic drift of these recognized epitope regions presents
a major obstacle to vaccine development since an
effective vaccination is possible only when the epi-
demic strain matches with the vaccine strain (5 ). HA
recognizes the host cell receptors containing glycans
with terminal sialic acids, and the precise linkage be-
tween them determines the species specificity. Non-
synonymous mutations in HA can alter the recogni-
tion from α-2,3-linked sialic acid to α-2,6-linked sialic
acid, which can permit the binding of avian viruses to
human receptors (6–8 ). This conversion in receptor-
binding from avian to human could be a major cause
of pandemics (8 ). Hence understanding the evolution
of HA is of great relevance for public health.
In the present study, we employed QUASI (9 ),
a selection mapping algorithm, for the identification
of positive selection (PS) sites on HA sequences of
influenza A virus subtype H5N1. The cornerstone of
selection mapping is the testing of each observed re-
placement mutation at each codon to identify those
particular replacement mutations that are overabun-
dant relative to silent mutations at that codon (9 ).
We mainly focused on the mutational events of HA
and addressed the following questions: How do mu-
tations change over time in HA under the influence
Genomics Proteomics Bioinformatics Vol. 7 No. 1–2 June 2009 47
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Evolution of H5N1 Hemagglutinin
of PS pressure and what is their functional impact?
What are the probable B-cell and T-cell epitopes?
How do known epitopes correspond with positively
selected substitutions? What are the phylogenetic re-
lationships within the H5N1 (and to a broader extent
H5N2, H5N3, H5N8 and H5N9) isolates of avian, hu-
man and other animals?
Results and Discussion
Identification and analysis of PS sites
Distribution of PS sites
The selection mapping algorithm QUASI (9 ) was used
to analyze the avian and human HA sequences iso-
lated during 1996–2007 to determine positively se-
lected sites. As a result, 33 and 34 PS sites were found
throughout avian and human HA sequences, respec-
tively (Figure 1; Tables 1 and 2). Some of the iden-
tified PS sites were reported in earlier studies (10–
12 ).
The HA gene has five types of epitope sites la-
beled A to E (Figure 1). The epitope sites seem to
be under high PS pressure, with more replacement
mutations than silent mutations compared with the
rest of the HA1 and the HA2 region. Changes in 41
codons within or near the epitope sites A and B of
H3 HA have been shown to be associated with anti-
genic drift (13 ). In the current study, several changes
were also observed in the epitope sites C, D and E
besides A and B of H5N1 HA. The predicted PS sites
were found to be mostly within or adjacent to epitope
sites while some in receptor-binding and glycosylation
sites. This noteworthy overlap of newly predicted PS
sites within the functional regions of HA is a causal
explanation of our findings and further emphasizes
the antigenic plasticity of H5N1.
Frequency of PS sites
The occuring frequency of PS sites in HA increased
from 1996 to 2007, which is possibly due to accumu-
lation of replacement mutations over time (Figure 2).
The increase of PS pressure in recent strains corrobo-
rates the epidemiological observation of the spread of
the virus from birds to humans and other species, sig-
nifying the effect of PS towards the diversity, adapt-
ability and lethality of the virus. Specifically, an in-
creasing number of amino acids under PS was ob-
served in 2001, and some of the mutations persisted
for several years (Tables 1 and 2). The biological rele-
vance of these respective mutations has to be further
studied. The H5N1 isolates during 2004–2006 have
several amino acid changes that alter their antigenic-
ity, compared with those in previous years (Tables 1
and 2). This observation is in accordance with prior
genetic and antigenic studies on H5N1 isolates (14 ).
Some of the identified host-specific PS sites might
be associated with viral adaptability to the selected
hosts.
Mutational changes of PS sites
We also analyzed the mutational changes of these
identified PS sites and had some interesting ob-
servations: (1) Amino acid substitutions 138L→Q,
140R→K and 156A→T continued in these years. The
amino acids at sites 138 and 140 are involved in the
carbohydrate specificity of HA molecule towards host
receptor (15 ). Substitution 156A→T is of particu-
lar interest, since the mutation introduces a new gly-
cosylation site at N154, consistent with a strategy
commonly used by influenza virus to mask or un-
mask antigenic sites from the immune system. This
change was found to be associated with viral adapta-
tion to terrestrial poultry that increased its virulence
for these birds (16–18 ). (2) Substitution 129S→L oc-
curred in 2003 and continued thereafter. Serine at site
129 is a receptor-binding site for α-2,3-linked sialic
acids. Structural study on the H5N1 HA has reported
that this change from serine to leucine facilitates ac-
cess to α-2,6-linked sialic acids (19 ). (3) An amino
acid change at receptor-binding site 189K→R ob-
served in 2003 was reported as an escape mutant (20 )
and was further clearly shown to be significantly anti-
genical (21 ). (4) Substitution 223S→N appeared in
2003 from human host was shown through genetic and
structural studies to increase the receptor-binding ca-
pacity of HA to human cell receptor (22 ). (5) Substi-
tution 94D→N observed in 2004–2005 from avian host
was found to alter the interaction of Y91, H179 and
L190 with sialosides, resulting in increased affinity
of HA for human receptors (14 ). In addition, the
significance of non-epitope PS sites with respect to
antigenicity has to be investigated structurally, since
some of the replacement mutations might influence
the key regions of HA, although to a lesser extent.
Amino acid property changes of PS sites
Some of the PS sites were observed in the solvent-
exposed region of HA. This is expected because the
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Explanation of codes used in the Figure 1
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Figure 1 Comparative representation of the distribution of PS sites in avian and human H5N1 HA sequences.
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Table 1 QUASI identif ied positive selection sites in H5N1 HA sequences isolated from avian hosts
Year Positive selection sites
HA1 HA2
1997 108 (I, T); 138 (L, H); 263 (T, A) –
2000 140 (R, K); 217 (S, P) –
2001 108 (I, T); 138 (L, H, Q); 156 (A, T); 174 (V, I); 212 (K, E); 217 (S,
P)
398 (R, K); 513 (T, I)
2002 108 (I, T); 156 (A, T) 483 (R, K); 511 (I, M)
2003 129 (L, S); 138 (L, Q); 140 (K, R); 155 (S, N); 156 (A, T); 189 (R, K) –
2004 86 (V, A); 94 (D, N); 108 (I, T); 124 (D, N); 129 (L, S); 138 (L, Q);
140 (K, R); 156 (A, T); 189 (R, K); 212 (R, K); 227 (E, D); 263 (T, A)
513 (T, I)
2005 71 (I, L); 82 (A, D); 86 (V, A); 94 (D, N); 108 (I, T); 124 (D, N); 129
(L, S); 140 (K, R); 141 (S, P); 154 (N, D); 155 (S, N, D); 156 (A, T);
189 (R, K); 217 (S, P); 227 (E, D); 252 (Y, N); 263 (T, A); 323 (R, G)
473 (K, R); 511 (I, M); 513 (T, I)
2006 36 (T, A); 71 (I, L); 129 (L, S); 141 (S, P); 154 (N, D); 155 (S, N, D);
156 (A, T); 252 (Y, N); 263 (T, A); 282 (I, M); 310 (R, K); 323 (G, R)
473 (K, R); 496 (A, S)
2007 36 (T, A); 54 (D, N); 71 (I, L); 129 (L, S); 137 (Y, H); 155 (S, N, D);
235 (P, S); 323 (G, R)
473 (K, R); 511 (I, M)
Table 2 QUASI identif ied positive selection sites in H5N1 HA sequences isolated from human hosts
Year Positive selection sites
HA1 HA2
1997 140 (R, K); 156 (A, S); 156 (A, T) 368 (Q, K)
2003 120 (S, N); 124 (N, S); 126 (D, E); 129 (L, S); 138 (L, Q); 140 (R, K);
155 (S, N); 156 (A, T); 189 (K, R); 217 (P, S); 223 (S, N)
–
2004 124 (N, S); 126 (D, E); 129 (L, S); 138 (L, Q); 139 (G, E); 140 (R, K);
156 (A, T); 217 (P, S)
–
2005 124 (N, D); 126 (D, E); 129 (L, S); 140 (R, S, K); 141 (S, P); 156 (A,
T); 162 (R, K); 217 (P, S)
–
2006 71 (L, I); 86 (A, T); 124 (N, S); 126 (D, E); 129 (L, S); 140 (R, S, T);
141 (S, P); 154 (N, D); 156 (A, T); 162 (R, K); 174 (V, I); 189 (R, K);
200 (V, I); 217 (P, S); 235 (P, S); 252 (Y, N); 263 (T, A); 269 (L, V);
282 (M, I); 310 (R, K); 323 (R, G)
473 (R, K); 482 (V, I); 537 (S, T)
2007 86 (A, T); 124 (N, S); 126 (D, E); 129 (L, S); 141 (S, P); 151 (I, T);
154 (N, D); 156 (A, T); 162 (R, K); 184 (A, E); 185 (A, E); 200 (V, I);
263 (T, A); 272 (G, S); 282 (I, M)
473 (R, K); 482 (V, I); 537 (S, F)
solvent accessible areas of HA provide essential adap-
tations required for the virus. Some of the epidemic
strains with the largest changes in solvent-exposed re-
gions have been reported to be lethal (4 ). Changes
of amino acid property at PS sites in avian HA oc-
curred in the following decreasing order: non-polar to
uncharged polar (NP→UP); UP→NP; acidic to ba-
sic (A→B); NP→NP; UP→A. Whereas in humans
the majority of the alterations at PS sites resulted in
NP→NP, followed by UP→UP and finally NP→UP.
The distinct changes in amino acid properties of avian
H5N1 HA might aid in its adaptability to diverse
species. To verify this observation, phylogenetic anal-
ysis was conducted.
Phylogenetic analysis
A phylogenetic tree was constructed based on HA
amino acid sequences from various hosts and clustered
into two specific groups (Figure 3A). Cluster A has
H5N1 strains from avian along with human, swine and
other animals. Cluster B contains H5N1 avian strains
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Figure 2 Average frequencies of positively selected amino acids of avian and human isolates of H5N1 virus from 1996
to 2007. Group I: Avian (1996, 1997) and Human (1997, 1998); Group II: Avian (1999, 2000, 2001); Group III: Avian
(2002, 2003, 2004) and Human (2003, 2004); Group IV: Avian (2005, 2006, 2007) and Human (2005, 2006, 2007); Cum:
Cumulative avian and human groups.
of 1991, 2001 and 2005 as well as H5N3 and H5N9
avian strains. Interestingly, the H5N1 avian strains
of Cluster B have lost the consensus polybasic cleav-
age site from ERRRKKR to E− − −−TR, which is
responsible for the high pathogenicity of H5N1. The
phylogenetic tree constructed using HA nucleotide se-
quences also clustered them into two specific groups
(Figure 3B). Cluster A has H5N1 strains from swine
and other animals while Cluster B contains human
and avian strains. The clustering of the nucleotide
sequences is interesting because we observed that the
nucleotide sequences of Cluster A have more silent
mutations than those of Cluster B. Maximum wobble-
based replacements were observed at the segment
packing region of HA (positions 540–565) (23 ) from
swine and other animals when compared with the
avian and human strains and that might influence the
viral adaptability at host level. It would be worth-
while to study the biological role of observed silent
mutations, since recent evidence suggests that syn-
onymous mutations may not be selectively neutral
(24 ).
The differences in clustering of sequences with
respect to nucleotide and amino acid level were ex-
pected since given a sufficient evolutionary time, con-
servation of a protein sequence will not necessarily be
matched at the nucleotide level for those amino acids
with multiple codons (23 ). The mean genetic dis-
tances between avian and human H5N1 HA sequences
from 1996 to 2007 were determined and presented in
Figure 4. This figure clearly elucidates that the vi-
ral drift is almost similar in both avian and human
species with a progressive trend over the years.
Epitope analysis
A recent report found significant knowledge gaps
in the studies concerned with the identification of
influenza A epitopes and suggested the need for
a more systematic and comprehensive collection of
influenza immune epitopes (25 ). With this in mind,
we conducted an epitope analysis on both avian and
human H5N1 HA sequences to identify probable ma-
jor histocompatibility complex (MHC) class I re-
stricted T-cell epitopes (CTL) and antibody (Ab)
epitopes. The peptide binders for HLA-B*2705 and
HLA-B*3501 class I MHC alleles of those H5N1 HA
sequences during 1996–2007 were predicted (Table
S1). Epitope analysis revealed conserved stretches
in the HA region, comprising important sites like
receptor-binding, glycosylation, polybasic cleavage
and other antigenic sites that might involve in the de-
termination of host specificity of H5N1. In addition
to CTL epitopes, antigenic peptide regions of HA that
might elicit antibody response (Ig) were predicted us-
ing the Kolaskar and Tongaonkar method (26 ) (Fig-
ure 1; Table S2).
To assess selection intensity, dN/dS ratio was de-
termined for all the predicted epitope regions, where
dN and dS stand for non-synonymous and synonymous
substitution rate, respectively. A dN/dS ratio >1
would be interpreted as evidence of positive selection
(13 ). Results showed that the dN/dS ratios for these
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Figure 3 A. Protein-based evolutionary relationship of H5N1 (avian, human, swine and other animals), H5N2, H5N3,
H5N8 and H5N9 (avian) HA genes using neighbor-joining tree construction. Bootstrap values of 2,500 replications are
shown on major branches.
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Figure 3 B. Nucleotide-based evolutionary relationship of H5N1 (avian, human, swine and other animals), H5N2,
H5N3, H5N8 and H5N9 (avian) HA genes using neighbor-joining tree construction. Bootstrap values of 2,500 replica-
tions are shown on major branches.
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Figure 4 Evolutionary rates for nucleic acids and proteins of H5N1 HA isolated from avian and human hosts.
Evolutionary rate is estimated by regression of year of isolation against branch distance from the common origin node
of the nucleotide and amino acid.
epitope regions were mostly <1, except for the CTL
epitope SRLVLATGL (positions 309–317) from hu-
man and the CTL epitope GREFNNLER (positions
397–405) conserved in both avian and human (Table
S1). The low evolution rate of these epitope regions
might be due to functional constraints. Most of the
epitope regions seem to be conserved in both avian
and human species, suggesting that there could be
possibility of inter-strain cross-reactivity for these epi-
tope regions, although species-specific epitopes exist.
Only a few PS sites were identified in these epitope
regions (Figure 1), signifying locally focused selection.
Therefore, responses to conserved epitopes might be
most useful with respect to broad spectrum vaccine
development, whereas species-specific epitopes might
be most useful for monitoring purposes.
Conclusion
To summarize, we predicted and analyzed PS sites
and epitope sites of the HA sequences of H5N1
influenza A virus, with the object of clarifying the
role of PS pressure on the evolution of H5N1 hemag-
glutinin. Analysis of the distribution, frequency and
mutation of the PS sites led to the observation that
known and newly identified PS sites are mostly dis-
tributed within or adjacent to epitope sites, thus we
concluded that the epitope sites are under high PS
pressure. To verify this observation, phylogenetic
analysis was conducted from HA sequences of vari-
ous hosts and a number of suggestive relationships
were observed. We also noted that the frequency of
PS sites increased from 1996 to 2007. Recent (2005–
2007) circulating strains had greater PS frequency
compared with the preceding strains and this might
implicate the role of these PS sites in increased diver-
sity. These findings are relevant in vaccine develop-
ment since effective vaccination is possible only if the
vaccine strain is antigenically similar to the current
circulating strains. In addition, some epitope regions
were found to have low rates of evolution and are con-
served in both avian and human species, suggesting
that there could be possibility of inter-strain cross-
reactivity for these epitope regions. Epitope analysis
showed that the CTL and B-cell epitopes in conserved
stretches of HA region are rarely targeted by PS sites
and hence may be good targets for effective vaccine
development for influenza A virus. Nevertheless, this
observation requires experimental verification. The
epitopes with PS sites also draw attention as possible
emerging escape variants.
Materials and Methods
HA sequences
The HA nucleotide sequences and corresponding pro-
tein sequences of H5N1 influenza A virus from
avian, human, swine and other animals (feline,
dog, civet and blowfly) isolated during 1996–2007
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were downloaded from the NCBI database (http://
www.ncbi.nlm.nih.gov/) and the Influenza Sequence
Database (http://www.flu.lanl.gov). An avian
isolate A/Goose/Guangdong/1/96 (Accession No.
AF144305) and a human isolate A/HongKong/156/97
(Accession No. AF036356) were used as root se-
quences for all the analyses. The human HA se-
quences used in the analysis include those isolated
from Asian patients (19 ). After removing redundant
sequences, 85 unique HA sequences from avian and
human were used in the analysis (Table S3).
Identification of PS sites using QUASI
algorithm
Sequence data were organized into four avian groups
[A-I (1996, 1997), A-II (1999, 2000, 2001), A-III
(2002, 2003, 2004) and A-IV (2005, 2006, 2007)] and
three human groups [H-I (1997, 1998), H-II (2003,
2004) and H-III (2005, 2006, 2007)] to investigate the
PS pressure on HA region over time. The QUASI
algorithm (9 ) was used to identify the positively se-
lected variants of each data group.
Sequence alignment and analysis
BioEdit, a biological sequence alignment editor (27 ),
was used for sequence analysis (http://www.mbio.
ncsu.edu/BioEdit/bioedit.html). Multiple sequence
alignments were performed using ClustalW (28 ) with
default parameters offered by BioEdit as an external
program.
Phylogenetic analysis and tree building
Phylogenetic analysis was performed by MEGA
software version 4.0 (http://www.megasoftware.net/)
(29 ) and phylogenetic trees were generated employ-
ing the neighbor-joining method. Tree topology was
evaluated by bootstrap analysis with 2,500 replicates
for estimation of branch length errors and confidence
intervals (30 ).
Estimating synonymous and non-
synonymous nucleotide substitutions
SNAP program (http://www.hiv.lanl.gov) was used
to calculate variance and covariance values of the
number of synonymous (dS) and non-synonymous
(dN) substitutions per site based on a set of codon-
aligned nucleotide sequences (13 ).
Epitope analysis
The Kolaskar and Tongaonkar method (http://
bio.dfci.harvard.edu/tools/antigenic.html) (26 ) was
applied to predict B-cell antigenic peptides based on
the occurrence of amino acid residues in experimen-
tally determined epitopes. The reported accuracy of
this method is about 75% (26 ). RANKPEP program
(http://bio.dfci.harvard.edu/tools/rankpep.html),
which uses position-specific scoring matrices or
profiles from sets of aligned known peptides to bind
to a given MHC molecule (31 ), was employed as the
predictor of MHC peptide binding. Epitope analysis
was conducted to identify CTL epitopes specific for
HLA-B*2705 and HLA-B*3501, which were identified
as preferred alleles in the influenza A virus specific
CTL response.
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